“Death Panel” for Drugs

The Centers for Medicare and Medicaid Services (CMS), in a proposed rule is calling for the use of a metric for rationing health care that was banned following the Obamacare death-panel debate. The proposed changes to Medicare Part B’s drug payment model would use reports incorporating data using quality-adjusted life year (QALYs) which has the potential to limit drug access for the elderly and physically disabled. Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.